2025 Clinical Trials Preview: Insights on Initiations and Projections - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trials: What to Expect in 2025 - a Preview of Trials Planned to Initiate and Estimated to Complete" report has been added to ResearchAndMarkets.com's offering.

This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2025.

Identify key analysis and segmentation of these trials by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, drug type, and DCT use.

Scope

• This report provides an overview of clinical trials that are planned to be initiated and projected to be completed in 2025 captured in the Pharma Intelligence Center until December 19, 2024.
• In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.

Reasons to Buy

• See a preview of the clinical trials that are planned to be initiated and those projected to be completed in 2025.
• Identify key analysis and segmentation of these trials by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, drug type, and DCT use.

Key Topics Covered:

• Tables and Figures
• Executive Summary
• Introduction
• Clinical Trials Planned to Initiate 2025
• Clinical Trials Estimated to Complete in 2025
• Key Findings

List of Figures

• Planned clinical trials, by phase and sponsor type
• Planned clinical trials, top industry sponsors, by phase
• Planned clinical trials, top non-industry sponsors, by phase
• Planned clinical trials, single-country or multinational, by sponsor type and phase
• Planned clinical trials, regions, by phase
• Planned clinical trials, regions, by phase and distribution
• Planned clinical trials, country, by phase
• Planned clinical trials, country, by phase and distribution
• Planned clinical trials, drug type, by phase and distribution
• Planned clinical trials, top therapy areas, by phase
• Planned clinical trials, top therapy areas, by phase and distribution
• Planned clinical trials, top indications, by phase
• Planned clinical trials, top indications, by phase and distribution
• Total planned DCTs, by therapeutic area
• Clinical trials estimated to complete, by phase
• Clinical trials estimated to complete, by status and phase distribution
• Clinical trials estimated to complete, by sponsor type and phase
• Clinical trials estimated to complete, by top industry sponsor and phase
• Clinical trials estimated to complete, by top non-industry sponsor and phase
• Single-country or multinational clinical trials estimated to complete, by region
• Clinical trials estimated to complete, by country
• Clinical trials estimated to complete, by therapy area and phase
• Total DCTs estimated to complete, by region and single-country or multinational
• DCTs estimated to complete, by therapy area and phase

For more information about this report visit https://www.researchandmarkets.com/r/ii4qoc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.